Skip to main content
. Author manuscript; available in PMC: 2009 Nov 16.
Published in final edited form as: Clin Med Ther. 2009;1:1497–1510. doi: 10.4137/cmt.s2365

Figure 3. Model for maraviroc mechanism of resistance.

Figure 3

Maraviroc binds to the transmembrane region of CCR5, thereby inducing confomational changes that cannot be recognized by R5 HIV-1 gp120. One mechanism of resistance involves changes in HIV-1 Env that permit recognition of maraviroc-bound CCR5. As such, resistant viruses are not blocked by increasing maraviroc doses.